Skip to main content
Clinical Trials/DRKS00005069
DRKS00005069
Completed
Not Applicable

ongitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ® in adults and GRAZAX® and SLIToneULTRA® in adults and children (5 – 17 years) in patients with allergic Rhinoconjunctivitis in GErmany - LARGE

ALK-Abelló Arzneimittel GmbH0 sites2,571 target enrollmentJuly 4, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
J30.1
Sponsor
ALK-Abelló Arzneimittel GmbH
Enrollment
2571
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2013
End Date
May 8, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Routine treatment with specific immunotherapy (AVANZ®/GRAZAX®/SLIToneULTRA®)

Exclusion Criteria

  • Contraindications of specific immunotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials